Stock Events

Stock Events

Bonesupport AB (publ) 

€29.02
47
-€0.64-2.16%Friday 15:28

Statistics

Day High
28.96
Day Low
28.94
52W High
30.32
52W Low
22.46
Volume
17
Avg. Volume
-
Mkt Cap
1.91B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Feb 16Expected
Q2 2026
Q3 2026
Next
0.1
0.11
0.12
0.13
Expected EPS
0.13463635412528
Actual EPS
N/A

Financials

12.07%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
107.15MRevenue
12.93MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2B4.XETRA. It's not an investment recommendation.
Microsoft
7
MSFT
NVIDIA
6
NVDA
Apple
5
AAPL
NVIDIA
4
NVD.XETRA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap111.95B
Stryker Corporation is a competitor due to its extensive range of orthopedic products, including bone substitutes and other materials for bone repair, directly competing with Bonesupport's offerings.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet Holdings, Inc. competes in the orthopedic market, offering products for joint reconstruction, bone healing, and dental implants, overlapping with Bonesupport's bone regeneration technologies.
Medtronic
MDT
Mkt Cap123.49B
Medtronic plc offers products for spinal and orthopedic conditions, including bone graft substitutes, competing in the same space as Bonesupport with its bone healing technologies.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its DePuy Synthes division, provides a wide range of orthopedic and neurosurgery products, including synthetic bone grafts, competing with Bonesupport's bone regeneration solutions.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific Corporation competes with Bonesupport through its interventional products, including those for chronic pain and spinal conditions, areas where bone healing products are utilized.
Globant.
GLOB
Mkt Cap2.02B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spine and orthopedic implants that compete with Bonesupport's bone regeneration technologies.
K2 Capital Acquisition
KTWO
Mkt Cap202.62M
K2M Group Holdings, Inc. (acquired by Stryker) specialized in spine and minimally invasive solutions, competing in the same market as Bonesupport with its focus on bone healing.
Orthofix Medical
OFIX
Mkt Cap369.44M
Orthofix Medical Inc. offers regenerative and orthopedic solutions, including bone growth therapies, making it a competitor to Bonesupport in the field of bone regeneration and healing.

About

Bonesupport Holding AB (publ) operates as a prominent orthobiologics firm, dedicated to the development and worldwide commercialization of injectable bioceramic bone graft alternatives. These solutions are utilized for filling bone voids across international markets, specifically targeting regions such as Europe and North America. The company's primary product line features CERAMENT Bone Void Filler, a synthetic material designed for injection, which is both moldable and drillable. Its composition includes hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol. Other key offerings are CERAMENT G, an injectable ceramic bone graft substitute infused with gentamicin, and CERAMENT V, a synthetic injectable bone void filler fortified with vancomycin. Beyond its commercialized products, Bonesupport actively pursues preclinical development, focusing on pioneering new solutions to stimulate bone regrowth. These research efforts address complex medical challenges such as trauma, revision arthroplasty, chronic osteomyelitis, oncology-related bone issues, and diabetic bone and foot infections. Established in 1999, the company's corporate headquarters are situated in Lund, Sweden.
Show More
CEO
Torbjorn Skold
Employees
160
Country
Sweden
ISIN
SE0009858152
WKN
000A2DTSD

Listings

STU
DE
2B4.STU
F
DE
2B4.F
MU
DE
2B4.MU
ST
SE
BONEX.ST

0 Comments

Share your thoughts

FAQs

What is Bonesupport AB (publ) stock price today?▼
The current price of 2B4.XETRA is €29.02 EUR — it has decreased by -2.16% in the past 24 hours. Watch Bonesupport AB (publ) stock price performance more closely on the chart.
What is Bonesupport AB (publ) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XETRA Stock Exchange exchange Bonesupport AB (publ) stocks are traded under the ticker 2B4.XETRA.
What is Bonesupport AB (publ) market cap?▼
Today Bonesupport AB (publ) has the market capitalization of 1.91B
When is the next Bonesupport AB (publ) earnings date?▼
Bonesupport AB (publ) is going to release the next earnings report on February 16, 2027.
What were Bonesupport AB (publ) earnings last quarter?▼
2B4.XETRA earnings for the last quarter are 0.12 EUR per share, whereas the estimation was 0.12 EUR resulting in a +5% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Bonesupport AB (publ) revenue for the last year?▼
Bonesupport AB (publ) revenue for the last year amounts to 107.15M EUR.
What is Bonesupport AB (publ) net income for the last year?▼
2B4.XETRA net income for the last year is 12.93M EUR.
How many employees does Bonesupport AB (publ) have?▼
As of November 8, 2026, the company has 160 employees.
In which sector is Bonesupport AB (publ) located?▼
Bonesupport AB (publ) operates in the Health & Wellness sector.
When did Bonesupport AB (publ) complete a stock split?▼
Bonesupport AB (publ) has not had any recent stock splits.
Where is Bonesupport AB (publ) headquartered?▼
Bonesupport AB (publ) is headquartered in Lund, Sweden.